Interestingly, the high expression of miR-100, miR-193a-3p and miR-193a-5p was also associated in the group of carcinoids with specific clinical and pathological characteristics of aggressiveness, thus supporting that – either interfering with mTOR pathway or modulating tumor cells in a more complex network – they are relevant actors in controlling tumor growth and progression in these tumors. Here, MTOR is linked to carcinoid tumor.